Abstract
Meniere’s disease was first described by Prosper Meniere in 1861 [1]. The classic disease description includes the tetrad of hearing loss, tinnitus, aural fullness, and vertigo spells. The disease tends to fluctuate and can be said to be predictably unpredictable. The spells can last from minutes to hours. Attacks can be associated with nausea, vomiting, headache, and fatigue. Medical management is sufficient for a majority of patients, but those who are recalcitrant may be a candidate for surgical intervention. Currently, a variety of surgical techniques are employed for patients with Meniere’s disease who have failed medical treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Meniere P. Sur une forme de surdite grave dependant d’une lesion de l’oreille interne. Gaz Med de Paris. 1861;16:29.
Dandy W. Effects on hearing after subtotal section of the cochlear branch of the auditory nerve. Bull Johns Hopkins Hosp. 1934;55:240–3.
Dandy W. The surgical treatment of Ménière’s disease. Surg Gynecol Obstet. 1941;72:421–5.
Lake R. Removal of semicircular canals in a case of unilateral aural vertigo. Lancet. 1904;1:421.
Cawthorne TE. The treatment of Ménière’s disease. J Laryngol Otol. 1943;58:363–71.
Portmann G. Vertigo, surgical treatment of opening of the saccus endolymphaticus. Arch Otolarygol Head Neck Surg. 6:309–19.
House WF. Subarachnoid shunt for drainage of endolymphatic hydrops. Laryngoscope. 1962;72:713–29.
Schuknecht HF. Cochlear endolymphatic shunt. Am J Otol. 1984;5:546–8.
Pou AM, Hirsch BE, Durrant JD, et al. The efficacy of tympanic electrocochleography in diagnosis of endolymphatic hydrops. Am J Otol. 1996;17(4):607–11.
Fischer LM, Derebery J. Oral steroid treatment for hearing improvement in Ménière’s disease and endolymphatic hydrops. Otol Neurotol. 2012;33(9):1685–91.
Balkany. The bilateral aspects of Meniere’ disease: an underestimated entity. Otolaryngol Clin N Am. 1980;12:603–9.
Shea JJ Jr. The role of dexamethasone or streptomycin perfusion in the treatment of Ménière’s disease. Otolaryngol Clin N Am. 1997;30(6):1051.
Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109:1–17.
Chandrasekhar SS, Rubinstein RY, Kwartler JA. Dexamethasone pharmacokinetics in the inner ear: comparison and use of facilitation agents. Otolaryngol Head Neck Surg. 2000;122(4):521–8.
McRackan TR, Best J, Pearce EC, Bennett ML, Dietrich M, Wanna GB, Haynes DS, Labadie RF. Intratympanic dexamethasone as a symptomatic treatment for Meniere’s disease. Otol Neurotol. 2014;35(9):1638–40.
Thomsen J, Bretlau P, Tos M, et al. Placebo effect in surgery for Ménière’s disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol. 1981;107(5):271.
Glasscock ME, et al. What I think of sac surgery in 1989. Am J Otol. 1989;10(3):230–3.
Pillsbury HC 3rd, Arenberg IK, Ferraro J, Ackley RS. Endolymphatic sac surgery. The Danish sham surgery study: an alternative analysis. Otolaryngol Clin N Am. 1983;16(1):123–7.
Welling DB, Nagaraja HN. Endolymphatic mastoid shunt: a reevaluation of efficacy. Otolaryngol Head Neck Surg. 2000;122(3):340.
Telischi FF, Luxford WM. Long-term efficacy of endolymphatic sac surgery for vertigo in Ménière’s disease. Otolaryngol Head Neck Surg. 1993;109(1):83.
Kato BM, LaRouere MJ, Bojrab DI, et al. Evaluating quality of life after endolymphatic sac surgery: the Meniere’s disease outcomes questionnaire. Otol Neurotol. 2004;25:339–44.
Sood A, Lambert P, et al. Endolymphatic sac surgery for Meniere’s disease: a systematic review and meta-analysis. Otol Neurotol. 2014;35:1033Y1045.
Paparella MM. Revision of endolymphatic sac surgery for recurrent Meniere’s disease. Otolaryngol Clin North Am. 2002;35(3):607–19.
Paparella MM1, Sajjadi H. Endolymphatic sac revision for recurrent Menière’s disease. Am J Otol. 1988;9(6):441–7.
Fowler EP. Streptomycin treatment for vertigo. Trans Am Acad Ophthalmol Otolaryngol. 1948;52:293–301.
Ohmori WH. Mechano-electrical transduction currents in isolated vestibular hair cells of the chick. J Physiol. 1985;359:189–217.
Waguespack J, Ricci A. Aminoglycoside ototoxicity: permeant drugs cause permanent hair cell loss. J Physiol. 2005;567:359–60.
Williams S, Zenner H, Schacht J. Three molecular steps of aminoglycoside ototoxicity demonstrated in outer hair cells. Hear Res. 1987;30:11–8.
Schuknecht HP. Ablation therapy for the relief of Meniere’s disease. Laryngoscope. 1956;66:859.
Graham MD, Sataloff RT, Kemink JL. Titration streptomycin therapy for bilateral Meniere’s disease: a preliminary report. Otolaryngol Head Neck Surg. 1984;92(4):440–7.
Magnusson M, Padoan S. Delayed onset of ototoxic effects of gentamicin in treatment of Menière’s disease. Rationale for extremely low dose therapy. Acta Otolaryngol. 1991;111(4):671–6.
Nedzelski J, Chiong C, Fradet G, et al. Intratympanic gentamicin instillation as treatment of unilateral Meniere’s disease: update of an ongoing study. Am J Otol. 1993;13:278–82.
Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, Arnos KS, Cortopassi GA, Jaber L, Rotter JI. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet. 1993;4(3):289–94.
Minor LB. Intratympanic gentamicin for control of vertigo in Meniere’s disease: vestibular signs that specify completion of therapy. Am J Otol. 1999;20(2):209.
Kaplan DM, Nedzelski JM, Chen JM, et al. Intratympanic gentamicin for the treatment of unilateral Meniere’s disease. Laryngoscope. 2000;110(8):1298.
Dandy WE. Ménière’s disease: its diagnosis and method of treatment. Arch Surg. 1928;16:1127–52.
Dandy WE. Treatment of Ménière’s disease by section of only the vestibular portion of the acoustic nerve. Bull Johns Hopkins Hosp. 1933;53:52–5.
House WF. Surgical exposure of the internal auditory canal and its contents through the middle cranial fossa. Laryngoscope. 1961;71:1363.
Silverstein H, Norrell H. Retrolabyrinthine surgery: a direct approach to the cerebellopontine angle. Otolaryngol Head Neck Surg. 1980;88:462–9.
Rosenberg S, Silverstein H, Hoffer M, et al. Hearing results after posterior fossa vestibular neurectomy. Otolaryngol Head Neck Surg. 1996;114:32–7.
Silverstein H, Norrell H, Smouha EE. Retrosigmoid-internal auditory canal approach vs. retrolabyrinthine approach for vestibular neurectomy. Otolaryngol Head Neck Surg. 1987;97(3):300–7.
Tewary AK, Riley N, Kerr AG. Long-term results of vestibular nerve section. J Laryngol Otol. 1998;112(12):1150–3.
Pappas DG Jr, Pappas DG Sr. Vestibular nerve section: long-term follow-up. Laryngoscope. 1997;107(9):1203–9.
Silverstein H, Norrell H, Rosenberg S. The resurrection of vestibular neurectomy: a 10-year experience with 115 cases. J Neurosurg. 1990;72(4):533–9.
Silverstein H, Jackson LE. Vestibular nerve section. Otolaryngol Clin N Am. 2002;35(3):655–73. ISSN 0030-6665
Setty BS, et al. Fully endoscopic Retrosigmoid vestibular nerve section for refractory Meniere disease. J Neurol Surg B. 2016;77(04):341–9.
House JW, Brackmann DE. Tinnitus: surgical management. Ciba Found Symp. 1981;85:204–16.
Hammerschlag PE, Schuknecht HF. Transcanal labyrinthectomy for intractable vertigo. Arch Otolaryngol. 1981;107:152–6.
Graham MD. Transmastoid labyrinthectomy: further experiences with the indications, complications, and early postoperative results. J Laryngol Otol. 1981;95:1205–11.
Kemink JL, Telian SA, Graham MD, Joynt L. Transmastoid labyrinthectomy: reliable surgical management of vertigo. Otolaryngol Head Neck Surg. 1989;101(1):5–10.
Zwolan TA, Shepard NT, Niparko JK. Labyrinthectomy with cochlear implantation. Am J Otol. 1993;14(3):220–3.
MacKeith SA, Bottrill ID, Ramsden JD. Simultaneous labyrinthectomy with cochlear implantation in patients with bilateral Ménière’s disease. Ann Otol Rhinol Laryngol. 2014;123(7):485–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jackson, N.M., LaRouere, M.J. (2019). Surgical Treatment of Meniere’s Disease. In: Babu, S., Schutt, C., Bojrab, D. (eds) Diagnosis and Treatment of Vestibular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-97858-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-97858-1_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-97857-4
Online ISBN: 978-3-319-97858-1
eBook Packages: MedicineMedicine (R0)